342 related articles for article (PubMed ID: 22743037)
81. The role of cytokines in the pathogenesis and treatment of HIV infection.
Catalfamo M; Le Saout C; Lane HC
Cytokine Growth Factor Rev; 2012; 23(4-5):207-14. PubMed ID: 22738931
[TBL] [Abstract][Full Text] [Related]
82. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
Sedaghat AR; Siliciano RF; Wilke CO
BMC Infect Dis; 2008 Jan; 8():2. PubMed ID: 18171475
[TBL] [Abstract][Full Text] [Related]
83. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.
Wang FX; Xu Y; Sullivan J; Souder E; Argyris EG; Acheampong EA; Fisher J; Sierra M; Thomson MM; Najera R; Frank I; Kulkosky J; Pomerantz RJ; Nunnari G
J Clin Invest; 2005 Jan; 115(1):128-37. PubMed ID: 15630452
[TBL] [Abstract][Full Text] [Related]
84. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
[TBL] [Abstract][Full Text] [Related]
85. Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients.
Petitjean G; Al Tabaa Y; Tuaillon E; Mettling C; Baillat V; Reynes J; Segondy M; Vendrell JP
Retrovirology; 2007 Aug; 4():60. PubMed ID: 17727722
[TBL] [Abstract][Full Text] [Related]
86. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.
Gálvez C; Grau-Expósito J; Urrea V; Clotet B; Falcó V; Buzón MJ; Martinez-Picado J
mBio; 2021 Dec; 12(6):e0307821. PubMed ID: 34844430
[TBL] [Abstract][Full Text] [Related]
87. A unified concept of HIV latency.
Bagasra O
Expert Opin Biol Ther; 2006 Nov; 6(11):1135-49. PubMed ID: 17049012
[TBL] [Abstract][Full Text] [Related]
88. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
[TBL] [Abstract][Full Text] [Related]
89. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation.
Li P; Kaiser P; Lampiris HW; Kim P; Yukl SA; Havlir DV; Greene WC; Wong JK
Nat Med; 2016 Jul; 22(7):807-11. PubMed ID: 27294875
[TBL] [Abstract][Full Text] [Related]
90. Block-And-Lock: New Horizons for a Cure for HIV-1.
Moranguinho I; Valente ST
Viruses; 2020 Dec; 12(12):. PubMed ID: 33334019
[TBL] [Abstract][Full Text] [Related]
91. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.
Bouchat S; Gatot JS; Kabeya K; Cardona C; Colin L; Herbein G; De Wit S; Clumeck N; Lambotte O; Rouzioux C; Rohr O; Van Lint C
AIDS; 2012 Jul; 26(12):1473-82. PubMed ID: 22555163
[TBL] [Abstract][Full Text] [Related]
92. HIV-1 reservoir dynamics in CD4+ T cells.
Bruner KM; Cohn LB
Curr Opin HIV AIDS; 2019 Mar; 14(2):108-114. PubMed ID: 30531293
[TBL] [Abstract][Full Text] [Related]
93. Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
Cunyat F; Rainho JN; West B; Swainson L; McCune JM; Stevenson M
J Virol; 2016 Jul; 90(14):6255-6262. PubMed ID: 27122585
[TBL] [Abstract][Full Text] [Related]
94. Latent reservoirs of HIV: obstacles to the eradication of virus.
Chun TW; Fauci AS
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):10958-61. PubMed ID: 10500107
[TBL] [Abstract][Full Text] [Related]
95. HIV Subtype and Nef-Mediated Immune Evasion Function Correlate with Viral Reservoir Size in Early-Treated Individuals.
Omondi FH; Chandrarathna S; Mujib S; Brumme CJ; Jin SW; Sudderuddin H; Miller RL; Rahimi A; Laeyendecker O; Bonner P; Yue FY; Benko E; Kovacs CM; Brockman MA; Ostrowski M; Brumme ZL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602611
[TBL] [Abstract][Full Text] [Related]
96. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.
Cameron PU; Saleh S; Sallmann G; Solomon A; Wightman F; Evans VA; Boucher G; Haddad EK; Sekaly RP; Harman AN; Anderson JL; Jones KL; Mak J; Cunningham AL; Jaworowski A; Lewin SR
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16934-9. PubMed ID: 20837531
[TBL] [Abstract][Full Text] [Related]
97. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
Colin L; Van Lint C
Retrovirology; 2009 Dec; 6():111. PubMed ID: 19961595
[TBL] [Abstract][Full Text] [Related]
98. Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance.
Olivetta E; Chiozzini C; Arenaccio C; Manfredi F; Ferrantelli F; Federico M
Cytokine Growth Factor Rev; 2020 Feb; 51():40-48. PubMed ID: 31926807
[TBL] [Abstract][Full Text] [Related]
99. HIV reservoirs and strategies for eradication.
Smith MZ; Wightman F; Lewin SR
Curr HIV/AIDS Rep; 2012 Mar; 9(1):5-15. PubMed ID: 22249405
[TBL] [Abstract][Full Text] [Related]
100. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
Siliciano RF
Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]